## Candidate studies 

"GSE136053" "GSE137136" "GSE137317" "GSE137803" "GSE51310"  "GSE52314" 
"GSE139073" "GSE51924"  "GSE139535" "GSE139929" "GSE139949" "GSE140064"
"GSE140627" "GSE141126" "GSE141309" "GSE141639" "GSE142025" "GSE143143"
 "GSE53949"  "GSE55567"  "GSE57896"  "GSE60424"  "GSE63887"  "GSE67141" 
 "GSE67543"  "GSE58557"  "GSE69889"  "GSE29660"  "GSE76268"  "GSE76308" 
 "GSE77108"  "GSE77522"  "GSE78922"  "GSE79668"  "GSE81076"  "GSE32874" 
 "GSE81608"  "GSE81547"  "GSE81965"  "GSE83139"  "GSE83699"  "GSE83781" 
 "GSE84133"  "GSE84714"  "GSE84814"  "GSE85241"  "GSE35296"  "GSE85527" 
 "GSE85530"  "GSE85531"  "GSE86611"  "GSE86884"  "GSE87340"  "GSE87626" 
 "GSE89360"  "GSE89475"  "GSE90028"  "GSE38447"  "GSE92724"  "GSE92772" 
 "GSE93709"  "GSE94019"  "GSE95243"  "GSE96562"  "GSE96563"  "GSE96564" 
 "GSE96568"  "GSE97084"  "GSE97205"  "GSE97591"  "GSE97647"  "GSE97655" 
 "GSE98485"  "GSE98675"  "GSE99068"  "GSE101207" "GSE102371" "GSE102498"
 "GSE102633" "GSE102677" "GSE104297" "GSE105052" "GSE106148" "GSE106177"
 "GSE106520" "GSE108413" "GSE109140" "GSE109265" "GSE110935" "GSE111876"
 "GSE114051" "GSE116369" "GSE116559" "GSE117469" "GSE44639"  "GSE120299"
 "GSE120904" "GSE50386"

## Studies that fit criteria

GSE137136: control vs cytokine

GSE52314: RNAs of human islets cells from diabetic vs control

GSE139929: HepG2 cells treated with astragalus polysaccharide and berberine vs control HepG2 cells

GSE141126: palmitic acid treatment conjugated to BSA vs BSA alone as control

GSE143143: all cells stimulated or unstimulated are monocyte-derived dendritic cells. Healthy donors unstimulated, healthy donors stimulated with healthy donor neutrophil extracellular traps, healthy donors stimulated with Type 1 diabetes neutrophil extracellular traps  vs Type 1 diabetes unstimulated, Type 1 diabetes stimulated with healthy donor neutrophil extracellular traps, Type 1 diabetes  stimulated with Type 1 diabetes neutrophil extracellular traps

GSE53949: pancreatic islet under palmitate exposure vs under control conditions

GSE140627: Gene regulation in type 1 diabetes renal function decliners and non renal function decliners

GSE57896: Obesity combated through conversion of white to brown adipocytes with different gene expression regulated using inhibitors of molecules that do the reverse of this conversion.

GSE60424: Gene regulation comparison between control and different immune-associated diseases. 

GSE67543: Alpha vs Beta and fetal vs adult contrasts

GSE76268: Gene expression differences between glucagon-secreting α-cells and insulin-secreting β-cells. add ATAC alpha vs ATAC beta

GSE77108: Gene expression regulated by HDAC inhibitors, in this case, SAHA, ep300 siRNA and C646 in diabetic and non-diabetic individuals. Add Healthy ctrl vs healthy treatment.

GSE77522: Gene expression regulated by treatment with metaformin in normoglycaemic and hyperglycaemic conditions

GSE84814: Gene expression differentially regulated in human pluripotent stem-cell-derived cardiomyocytes by glucose concentration. Change control group categorisation

GSE35296: Gene expression differentially regulated in human islet of Langerhans by pro-inflammatory cytokines interleukin-1β

GSE85530: Gene expression differentially regulated in CD8+ T cells unstimulated, stimulated with anti-CD3 and anti-CD28 or stimulated with anti-CD3 and anti-CD28 and PVR-Fc treatment (3 comparison groups). Which group comparisons

GSE85531: Gene expression differentially regulated in CD8+ T cells. Comparison groups can be responders, non responders and control and/or visit months.

GSE86611: Gene expression differentially regulated in human islets by Asf1B overexpression.

GSE87626: Genes expression differentially regulated in cancer cells by the suppression of mNT.

GSE90028: Genes expression differentially regulated in type 2 diabetic human serum samples. (Cx and HE were both control and A1C is T2 diabetes)

GSE97655: alpha vs beta cells

GSE98485: control (siCTL) vs SRp55 (siSR#2)

GSE106148: non-diabetic control versus type 1 diabetes (T1D)

GSE108413: control vs cytokine treatment

GSE109140: gene expression changes in HepG2 cells in response to hyperglycemia and valproic acid

GSE111876:CD3+ T cells of nondiabetic individuals vs type 1 diabetes

GSE114051:Comparison of WT and GLIS3-/- cells at various stages of human pancreatic differentiation???

GSE116369: BCL11A control vs BCL11A knockdown

GSE102371: no replicates but vital information on diabetes, islets of Langerrhans preparations in normo-glycemic individuals, long duration type 1 diabetes, short duration type 1 diabetes

GSE117469:pericytes and endothelial cells differentiated from iPS cells cultured in controlled, diabetic or diabetic media supplemented (pDAPT) (the primary cells were excluded)

GSE120904: Gene expression profiles of human tissue-resident IE-CTLs (both in vitro and ex vivo), before and after simulation with IL-15 and IL-21 (individually and in combination)

GSE50386: Pancreatic islets from 6 donors and separate populations of alpha, beta, and exocrine cells used in RNA-Seq analysis

GSE106177: Human primary cardiac mesenchymal cells (CMSC) from 7 diabetic (D) and 7 non-diabetic (ND) donors were analyzed after few rounds of ex vivo expansion

GSE97205: Addipose tissue comparisons. fiBAT vs OME vs SUB

GSE92772: Whole blood cells, normal glucose tolerant vs gestational diabetes. Two different contrasts for different sequencing

GSE92724: Diabetic patients (Pat) vs Ctrl

GSE97084: Exercise programs related to protein expression, including insulin sensitivity. Compare young vs young and old vs old (pre vs post) for each different training.

GSE94019: non-diabetic retinal endothelial cells versus proliferative diabetic retinopathy fibrovascular membrane endothelial cells 

GSE96563: Bulk-cell RNA-SEQ of unstimulated, anti-CD3 anti-CD28 stimulated and tetramer stimulated T cell clones

## Studies that don't fit criteria

GSE137803: no replicates

GSE136053: no sample descriptions

GSE137317: no replicates 

GSE139073: not related to diabetes

GSE51310: no replicates

GSE51924: no replicates

GSE140064: no replicates

GSE55567: no replicates

GSE63887: no clear differentiation between datasets (i.e. no ctrl vs study or something like this) and therefore contrast doesn't seem possible without another study or more data

GSE67141: not directly related to diabetes also no replicates

GSE76308: no replicates

GSE58557: not related to diabetes

GSE69889: Gene expression differentiated according to molecular clock.

GSE84133: Not contrasts based

GSE84714: Not contrasts based

GSE85241: No clear/relevant contrasts

GSE85527: Single cell RNA seq

GSE86884: Not related to diabetes.

GSE89360: Not related to diabetes.

GSE89475: Only 2 replicates

GSE38447: No replicates and ChIP-seq analysis

GSE97647: no replicates

GSE99068: Sorted NK cells from obese and lean peripheral blood mononuclear cells (PBMC) in IL6Ra+ and IL6Ra-, (the mouse samples were excluded)

GSE101207: Human Pancreatic islet from non-diabetic donor versus Type II diabetic donor (the mouse samples were excluded)

GSE102498: based on coronary artery disease

GSE106520: focuses on intracranial aneurysms

GSE109265: no replicates???

GSE110935: has mouse samples???

GSE44639: different instruments used???

GSE120299: not enough replicates for the treatment group

GSE116559: only has control groups and no groups to compare with

GSE97591: No replications

GSE93709: No replications

GSE95243: not related to diabetes

GSE96562: single-cell RNA-SEQ not included

GSE96564: single-cell RNA-seq of CD8+ influenza-reactive T cells

GSE96568: single-cell RNA-seq not included

## Contrasts

SRP221142:Genes differentially regulated by pro-inflammatory cytokines:Ctrl; SRX6821381,SRX6821383,SRX6821385,SRX6821387,SRX6821389:PIC; SRX6821382,SRX6821384,SRX6821386,SRX6821388,SRX6821390

SRP032953:Down regulation of miRNA contributing to T2DM:Ctrl; SRX376828,SRX376829,SRX376830:T2DM;SRX376831,SRX376832,SRX376833,SRX376834

SRP228577:Genes differentially regulated by insulin induction and APBBR treatment:Ctrl; SRX7100386,SRX7100387,SRX7100388:APBBR; SRX7100383,SRX7100384,SRX7100385

SRP228577:Genes differentially regulated by insulin induction:Ctrl; SRX7100386,SRX7100387,SRX7100388:II; SRX7100389,SRX7100390,SRX7100391

SRP233503:Genes differentially regulated by free fatty acids in HUVECs cells:Ctrl; SRX7228895,SRX7228896,SRX7228897:FFA; SRX7228898,SRX7228899,SRX7228900;

SRP239527:Genes expressed differenially in unstimulated healthy donor cells vs unstimulated type 1 diabetes cells:HDOunstim; SRX7503269,SRX7503270,SRX7503271,SRX7503272,SRX7503273:T1Dunstim; SRX7503284,SRX7503285,SRX7503286,SRX7503287,SRX7503288

SRP239527:Genes expressed differenially in unstimulated healthy donor cells vs type 1 diabetes cells stimulated by Neutrophil extracellular traps from healthy donor cells:HDOunstim; SRX7503269,SRX7503270,SRX7503271,SRX7503272,SRX7503273:T1D+HDONET;SRX7503289,SRX7503290,SRX7503291,SRX7503292,SRX7503293

SRP239527:Genes expressed differenially in unstimulated healthy donor cells vs type 1 diabetes cells stimulated by Neutrophil extracellular traps from type 1 diabetes cells:HDOunstim; SRX7503269,SRX7503270,SRX7503271,SRX7503272,SRX7503273:T1D+T1DNET; SRX7503294,SRX7503295,SRX7503296,SRX7503297,SRX7503298

SRP239527:Genes expressed differenially in healthy donor cells stimulated by Neutrophil extracellular traps from healthy donor cells vs unstimulated type 1 diabetes cells:HDO+HDONET; SRX7503274,SRX7503275,SRX7503276,SRX7503277,SRX7503278:T1Dunstim; SRX7503284,SRX7503285,SRX7503286,SRX7503287,SRX7503288

SRP239527:Genes expressed differenially in healthy donor cells stimulated by Neutrophil extracellular traps from healthy donor cells vs type 1 diabetes cells stimulated by Neutrophil extracellular traps from healthy donor cells:HDO+HDONET; SRX7503274,SRX7503275,SRX7503276,SRX7503277,SRX7503278:T1D+HDONET;SRX7503289,SRX7503290,SRX7503291,SRX7503292,SRX7503293

SRP239527:Genes expressed differenially in healthy donor cells stimulated by Neutrophil extracellular traps from healthy donor cells vs type 1 diabetes cells stimulated by Neutrophil extracellular traps from type 1 diabetes cells:HDO+HDONET; SRX7503274,SRX7503275,SRX7503276,SRX7503277,SRX7503278:T1D+T1DNET; SRX7503294,SRX7503295,SRX7503296,SRX7503297,SRX7503298

SRP239527:Genes expressed differenially in healthy donor cells stimulated by Neutrophil extracellular traps from type 1 diabetes cells vs unstimulated type 1 diabetes cells:HDO+T1DNET; SRX7503279,SRX7503280,SRX7503281,SRX7503282,SRX7503283:T1Dunstim; SRX7503284,SRX7503285,SRX7503286,SRX7503287,SRX7503288

SRP239527:Genes expressed differenially in healthy donor cells stimulated by Neutrophil extracellular traps from type 1 diabetes cells vs type 1 diabetes cells stimulated by Neutrophil extracellular traps from healthy donor cells:HDO+T1DNET; SRX7503279,SRX7503280,SRX7503281,SRX7503282,SRX7503283:T1D+HDONET;SRX7503289,SRX7503290,SRX7503291,SRX7503292,SRX7503293

SRP239527:Genes expressed differenially in healthy donor cells stimulated by Neutrophil extracellular traps from type 1 diabetes cells vs type 1 diabetes cells stimulated by Neutrophil extracellular traps from type 1 diabetes cells:HDO+T1DNET; SRX7503279,SRX7503280,SRX7503281,SRX7503282,SRX7503283:T1D+T1DNET; SRX7503294,SRX7503295,SRX7503296,SRX7503297,SRX7503298

SRP035268:Genes expressed differentially regulated by saturated fatty acids in Pancreatic beta-cells:Ctrl;SRX424352,	SRX424354,SRX424356,SRX424358,SRX424360:SFA;SRX424353,SRX424355,SRX424357,SRX424359,SRX424361,

SRP230455:Genes expressed differentially in those that have type 1 diabetes and have declining renal functionality and healthy individuals:Ctrl;	SRX7177515,SRX7177516:Decliners; SRX7177517,SRX7177518,SRX7177522,SRX7177524

SRP042186: Genes expressed differentially regulated by treatment of human white adipose tissue with 24 hours of JAK inhibition:Ctrl; SRX550549,SRX550550,SRX550551:WATJAKinhibitortreatment24hr; SRX550552,SRX550553,SRX550554

SRP042186: Genes expressed differentially regulated by treatment of human white adipose tissue with 24 hours of SYK inhibition:Ctrl; SRX550549,SRX550550,SRX550551:WATSYKinhibitortreatment24hr; SRX550555,SRX550556,SRX550557

SRP042186: Genes expressed differentially regulated by treatment of human white adipose tissue with 7 days of JAK inhibition:Ctrl; SRX550564,SRX550565,SRX550566:WATJAKinhibitortreatment7day; SRX550567,SRX550568,SRX550569

SRP042186: Genes expressed differentially regulated by treatment of human white adipose tissue with 7 days of SYK inhibition:Ctrl; SRX550564,SRX550565,SRX550566:WATSYKinhibitortreatment7day;SRX550570,SRX550571,SRX550572

SRP042186: Genes expressed differentially in human white vs brown adipose tissue with 24 hours of control treatment:White; SRX550549,SRX550550,SRX550551:Brown:SRX550561,SRX550562,SRX550563

SRP045500: Genes expressed differentially in human neutrophils with type 1 diabetes:Ctrl; SRX680546,SRX680607,SRX680614,SRX680628:Diabetes; SRX680562,SRX680568,SRX680642,SRX680648

SRP045500: Genes expressed differentially in human monocytes with type 1 diabetes:Ctrl; SRX680547,SRX680608,SRX680615,SRX680629:Diabetes; SRX680563,SRX680569,SRX680643,SRX680649

SRP045500:Genes expressed differentially in human B-cells with type 1 diabetes:Ctrl; SRX680548,SRX680609,SRX680616,SRX680630:Diabetes; SRX680564,SRX680570,SRX680644,SRX680650

SRP045500:Genes expressed differentially in human CD4 with type 1 diabetes:Ctrl; SRX680549,SRX680610,SRX680617,SRX680631:Diabetes; SRX680565,SRX680571,SRX680645,SRX680651

SRP045500:Genes expressed differentially in human CD8 with type 1 diabetes:Ctrl; SRX680550,SRX680611,SRX680618,SRX680632:Diabetes; SRX680566,SRX680572,SRX680646,SRX680652

SRP045500:Genes expressed differentially in human NK with type 1 diabetes:Ctrl; SRX680551,SRX680612,SRX680619,SRX680633:Diabetes; SRX680567,SRX680653

SRP045500:Genes expressed differentially in human whole blood with type 1 diabetes:Ctrl;SRX680541,SRX680613,
SRX680620,SRX680634:Diabetes; SRX680544,SRX680545,SRX680647,SRX680654

SRP056835:Genes expressed differentially in human pancreatic alpha and beta cells:Alpha; SRX977631,SRX977632,SRX977633,		
SRX977634,SRX977635,SRX977636,SRX977637,SRX977638,SRX977639,SRX977640,SRX977641:Beta; SRX977624,SRX977625,SRX977626,	SRX977627,SRX977628,SRX977629,SRX977630,SRX977642,SRX977643,SRX977644,SRX977645,SRX977646,SRX977647

SRP056835:Genes expressed differentially in human pancreatic adult and fetal cells:Adult; SRX977624,SRX977625,SRX977626,	SRX977627,SRX977628,SRX977629,SRX977630,SRX977631,SRX977632,SRX977633,SRX977634,SRX977635,SRX977636:Fetal; SRX977637,SRX977638,SRX977639,SRX9776340,SRX977641,SRX977642,SRX977643,SRX977644,SRX977645,SRX977646,SRX977647

SRP067701:Genes expressed differentially in glucagon-secreting α-cells and insulin-secreting β-cells:Alpha; SRX1497368,SRX1497369,SRX1497370,SRX1497371,SRX1497372,SRX1497373,SRX1497374:Beta; SRX1497375,SRX1497376,SRX1497377,SRX1497378,SRX1497379,SRX1497380,SRX1497381,SRX1497382

SRP068733:Genes expressed differentially in diabetic endothelial cells treated with SAHA:Ctrl; SRX1540354,SRX1540355,SRX1540356:SAHA; SRX1540357,SRX1540358,SRX1540359

SRP068733:Genes expressed differentially in diabetic endothelial cells treated with C646:Ctrl; SRX1540354,SRX1540355,SRX1540356:C646;SRX1540360,SRX1540361,SRX1540362

SRP068733:Genes expressed differentially in diabetic endothelial cells treated with ep300 siRNA compared to diabetic cells treated with DMSO:Ctrl;SRX1540354,SRX1540355,SRX1540356:ep300siRNA;SRX1540366,SRX1540367,SRX1540368

SRP068733:Genes expressed differentially in diabetic endothelial cells treated with ep300 siRNA compared to non-target siRNA:Non-target;SRX1540363,SRX1540364,SRX1540365:ep300siRNA;SRX1540366,SRX1540367,SRX1540368

SRP068733:Genes expressed differentially in healthy endothelial cells treated with SAHA:Ctrl;	SRX1540339,SRX1540340,SRX1540341:SAHA; SRX1540342,SRX1540343,SRX1540344

SRP068733:Genes expressed differentially in healthy endothelial cells treated with C646:Ctrl; SRX1540339,SRX1540340,SRX1540341:C646; SRX1540345,SRX1540346,SRX1540347

SRP068733:Genes expressed differentially in healthy endothelial cells treated with ep300 siRNA compared to healthy cells treated with DMSO:Ctrl;SRX1540339,SRX1540340,SRX1540341:ep300siRNA;	SRX1540351,SRX1540352,SRX1540353

SRP068733:Genes expressed differentially in diabetic endothelial cells treated with ep300 siRNA compared to non-target siRNA:Non-target;SRX1540348,SRX1540349,SRX1540350:ep300siRNA;	SRX1540351,SRX1540352,SRX1540353

SRP069228:Genes expressed differentially in healthy human endothelial cells treated with metaformin:Ctrl; SRX1558510,SRX1558511,SRX1558512:Meta; SRX1558513,SRX1558514,SRX1558515

SRP069228:Genes expressed differentially in healthy human endothelial cells treated with metaformin and 30mM of D-glucose:Ctrl; SRX1558516,SRX1558517,SRX1558518:Meta;SRX1558519,SRX1558520,SRX1558521

SRP079700:Gene expression differentially regulated in human pluripotent stem-cell-derived cardiomyocytes by glucose concentration 0 mM for 5 days and back to Glucose 25 mM for 5 days:Ctrl;SRX1975929,SRX1975930,SRX1975931:G0mMto25mM;	SRX1975932,SRX1975933,SRX1975934

SRP079700:Gene expression differentially regulated in human pluripotent stem-cell-derived cardiomyocytes by glucose concetration of 25 mM:Ctrl;SRX1975929,SRX1975930,SRX1975931:G25mM;SRX1975935,SRX1975936,SRX1975937

SRP010483:Gene expression differentially regulated in human islet of Langerhans by pro-inflammatory cytokines interleukin-1β:Ctrl; SRX117470,SRX117472,SRX117474,SRX117476,SRX117478:interleukin-1β;SRX117471,SRX117473,SRX117475,SRX117477,SRX117479

SRP081574:Gene expression differentially regulated in CD8+ T cells stimulated with anti-CD3 and anti-CD28:Ctrl;SRX2018467,SRX2018468,SRX2018469,SRX2018470,SRX2018471,SRX2018472,SRX2018473,SRX2018474:StimUntreat; SRX2018475,SRX2018476,SRX2018477,SRX2018478,SRX2018479,SRX2018480,SRX2018481,SRX2018489,SRX2018490,SRX2018491,SRX2018492,SRX2018493,SRX2018494,SRX2018495,SRX2018501,SRX2018502,SRX2018503,SRX2018504,SRX2018505,SRX2018506,SRX2018507,SRX2018508,SRX2018509,SRX2018516,SRX2018517,SRX2018518,SRX2018519,SRX2018520,SRX2018522,SRX2018524

SRP081574:Gene expression differentially regulated in CD8+ T cells stimulated with anti-CD3 and anti-CD28 and PVR-Fc treatment:Ctrl;Ctrl;SRX2018467,SRX2018468,SRX2018469,SRX2018470,SRX2018471,SRX2018472,SRX2018473,SRX2018474:StimTreat;	SRX2018482,SRX2018483,SRX2018484,SRX2018485,SRX2018486,SRX2018487,SRX2018488,SRX2018496,SRX2018497,SRX2018498,SRX2018499,	SRX2018510,SRX2018511,SRX2018512,SRX2018513,SRX2018514,SRX2018515,SRX2018521,SRX2018523,SRX2018525,SRX2018526,SRX2018527,SRX2018528,SRX2018529

SRP081574:Gene expression differentially regulated in CD8+ T cells stimulated with anti-CD3 and anti-CD28 vs anti-CD3 and anti-CD28 and PVR-Fc treatment:StimUntreat; SRX2018475,SRX2018476,SRX2018477,SRX2018478,SRX2018479,SRX2018480,SRX2018481,SRX2018489,SRX2018490,SRX2018491,SRX2018492,SRX2018493,SRX2018494,SRX2018495,SRX2018501,SRX2018502,SRX2018503,SRX2018504,SRX2018505,SRX2018506,SRX2018507,SRX2018508,SRX2018509,SRX2018516,SRX2018517,SRX2018518,SRX2018519,SRX2018520,SRX2018522,SRX2018524:StimTreat; SRX2018482,SRX2018483,SRX2018484,SRX2018485,SRX2018486,SRX2018487,SRX2018488,SRX2018496,SRX2018497,SRX2018498,SRX2018499,	SRX2018510,SRX2018511,SRX2018512,SRX2018513,SRX2018514,SRX2018515,SRX2018521,SRX2018523,SRX2018525,SRX2018526,SRX2018527,SRX2018528,SRX2018529

SRP087720:Gene expression differentially regulated in human islets by Asf1B overexpression:Ctrl; SRX2153424,SRX2153425,SRX2153426,SRX2153427,SRX2153428,SRX2153429,SRX2153430,SRX2153431,SRX2153432,SRX2153433:Asf1B;	SRX2153434,SRX2153435,SRX2153436,SRX2153437,SRX2153438,SRX2153439,SRX2153440,SRX2153441,SRX2153442,SRX2153443

SRP093728:Genes expression differentially regulated in type 2 diabetic human serum samples:Ctrl;SRX2359251,SRX2359252,SRX2359253,SRX2359254,SRX2359255,SRX2359256,SRX2359257,SRX2359258,SRX2359268,SRX2359269,SRX2359270,SRX2359271,SRX2359272,SRX2359273,SRX2359274,SRX2359275:T2DM;	SRX2359235,SRX2359236,SRX2359237,SRX2359238,SRX2359239,SRX2359240,SRX2359241

SRP103811:alpha cells versus beta cells from three East-Asian non-diabetic subjects:alpha;SRX2733099,SRX2733104,SRX2733110,SRX2733111,SRX2733112,SRX2733113,SRX2733115,SRX2733117,SRX2733119,SRX2733123,SRX2733126,SRX2733128,SRX2733130,SRX2733132,SRX2733133,SRX2733135,SRX2733140,SRX2733141,SRX2733143,SRX2733146,SRX2733147,SRX2733149,SRX2733150,SRX2733151,SRX2733153,SRX2733156,SRX2733157,SRX2733158,SRX2733159,SRX2733160,SRX2733161,SRX2733162,SRX2733163,SRX2733164,SRX2733170,SRX2733177,SRX2733180,SRX2733183,SRX2733184,SRX2733187,SRX2733189,SRX2733190,SRX2733191,SRX2733192,SRX2733205,SRX2733206,SRX2733210,SRX2733211,SRX2733212,SRX2733212,SRX2733213,SRX2733213,SRX2733215,SRX2733215,SRX2733216,SRX2733216,SRX2733217,SRX2733217,SRX2733218,SRX2733218,SRX2733221,SRX2733221,SRX2733222,SRX2733222,SRX2733223,SRX2733223,SRX2733224,SRX2733224,SRX2733225,SRX2733225,SRX2733228,SRX2733228,SRX2733229,SRX2733229,SRX2733231,SRX2733231,SRX2733232,SRX2733232,SRX2733233,SRX2733233,SRX2733234,SRX2733234,SRX2733235,SRX2733235,SRX2733237,SRX2733237,SRX2733238,SRX2733238,SRX2733243,SRX2733243,SRX2733247,SRX2733247,SRX2733248,SRX2733248,SRX2733249,SRX2733249,SRX2733250,SRX2733250,SRX2733251,SRX2733251,SRX2733252,SRX2733252,SRX2733253,SRX2733253,SRX2733255,SRX2733255,SRX2733256,SRX2733256,SRX2733257,SRX2733257,SRX2733258,SRX2733258,SRX2733259,SRX2733259,SRX2733260,SRX2733260,SRX2733261,SRX2733261,SRX2733262,SRX2733262,SRX2733263,SRX2733263,SRX2733264,SRX2733264,SRX2733265,SRX2733265,SRX2733266,SRX2733266,SRX2733268,SRX2733268,SRX2733269,SRX2733269,SRX2733270,SRX2733270,SRX2733271,SRX2733271,SRX2733272,SRX2733272,SRX2733273,SRX2733273,SRX2733274,SRX2733274,SRX2733275,SRX2733275,SRX2733276,SRX2733276,SRX2733277,SRX2733277,SRX2733278,SRX2733278,SRX2733279,SRX2733279,SRX2733280,SRX2733280,SRX2733281,SRX2733281,SRX2733282,SRX2733282,SRX2733283,SRX2733283,SRX2733285,SRX2733285,SRX2733286,SRX2733286,SRX2733287,SRX2733287,SRX2733289,SRX2733289,SRX2733290,SRX2733290,SRX2733291,SRX2733291,SRX2733292,SRX2733292,SRX2733293,SRX2733293,SRX2733294,SRX2733294,SRX2733295,SRX2733295,SRX2733303,SRX2733303,SRX2733305,SRX2733305,SRX2733316,SRX2733316,SRX2733317,SRX2733317:beta;SRX2733100,SRX2733101,SRX2733102,SRX2733103,SRX2733105,SRX2733106,SRX2733107,SRX2733108,SRX2733109,SRX2733114,SRX2733116,SRX2733118,SRX2733120,SRX2733121,SRX2733122,SRX2733124,SRX2733125,SRX2733127,SRX2733129,SRX2733131,SRX2733134,SRX2733136,SRX2733137,SRX2733138,SRX2733139,SRX2733142,SRX2733144,SRX2733145,SRX2733148,SRX2733152,SRX2733154,SRX2733155,SRX2733165,SRX2733166,SRX2733167,SRX2733168,SRX2733169,SRX2733171,SRX2733172,SRX2733173,SRX2733174,SRX2733175,SRX2733176,SRX2733178,SRX2733179,SRX2733181,SRX2733182,SRX2733185,SRX2733186,SRX2733188,SRX2733193,SRX2733194,SRX2733195,SRX2733196,SRX2733197,SRX2733198,SRX2733199,SRX2733200,SRX2733201,SRX2733202,SRX2733203,SRX2733204,SRX2733207,SRX2733208,SRX2733209,SRX2733214,SRX2733214,SRX2733219,SRX2733219,SRX2733220,SRX2733220,SRX2733226,SRX2733226,SRX2733227,SRX2733227,SRX2733230,SRX2733230,SRX2733236,SRX2733236,SRX2733239,SRX2733239,SRX2733240,SRX2733240,SRX2733241,SRX2733241,SRX2733242,SRX2733242,SRX2733244,SRX2733244,SRX2733245,SRX2733245,SRX2733246,SRX2733246,SRX2733254,SRX2733254,SRX2733267,SRX2733267,SRX2733284,SRX2733284,SRX2733288,SRX2733288,SRX2733296,SRX2733296,SRX2733297,SRX2733297,SRX2733298,SRX2733298,SRX2733299,SRX2733299,SRX2733300,SRX2733300,SRX2733301,SRX2733301,SRX2733302,SRX2733302,SRX2733304,SRX2733304,SRX2733306,SRX2733306,SRX2733307,SRX2733307,SRX2733308,SRX2733308,SRX2733309,SRX2733309,SRX2733310,SRX2733310,SRX2733311,SRX2733311,SRX2733312,SRX2733312,SRX2733313,SRX2733313,SRX2733314,SRX2733314,SRX2733315,SRX2733315,SRX2733318,SRX2733318,SRX2733319,SRX2733319,SRX2733320,SRX2733320,SRX2733321,SRX2733321;

SRP106195:human insulin-producing EndoC-βH1 cell line exposed to control (siCTL) versus knockdown (SRpP55):siCTL;SRX2779450,SRX2779451,SRX2779452,SRX2779453,SRX2779454:SRpP55;SRX2779455,SRX2779456,SRX2779457,SRX2779458,SRX2779459;

SRP121445:non-diabetic control versus type 1 diabetes (T1D):control;SRX3325355,SRX3325356,SRX3325357, SRX3325358,SRX3325359:T1D;SRX3325360,SRX3325361,SRX3325362;age,sex

SRP127362:control vs cytokine treatment:control;SRX3503795,SRX3503797,SRX3503799,SRX3503801,SRX3503803:cytokine treatment; SRX3503796,SRX3503798,SRX3503800,SRX35038002,SRX3503804;

SRP128998:high glucose versus high glucose VPA (valproic acid):high glucose;SRX3557428,SRX3557429, SRX3557430:high glucose VPA;SRX3557431,SRX3557432,SRX3557433;

SRP128998:low glucose versus low glucose VPA (valproic acid):low glucose;SRX3557434,SRX3557435,SRX3557436: low glucose VPA;SRX3557437,SRX3557438,SRX3557439;

SRP135788:CD3+ T cells of nondiabetic individuals vs type 1 diabetes:nondiabetic;SRX3797556SRX3797557,SRX3797558,SRX3797559,SRX3797560,SRX3797561,SRX3797562,SRX3797563,SRX3797564,SRX3797565,SRX3797566,SRX3797567,SRX3797568,SRX3797569,SRX3797570,SRX3797571,SRX3797572,SRX3797573,:type 1 diabetes;SRX3797574,SRX3797575,SRX3797576,SRX3797577,SRX3797578,SRX3797579,SRX3797580,SRX3797581,SRX3797582,SRX3797583,SRX3797584,SRX3797585,SRX3797585,SRX3797586,SRX3797587,SRX3797588,SRX3797589,SRX3797590,SRX3797591,SRX3797592,SRX3797593,SRX3797594,SRX3797595,SRX3797596,SRX3797597,SRX3797598,SRX3797599,SRX3797600,SRX3797601,SRX3797602,SRX3797603,SRX3797604;

SRP151530:BCL11A control vs BCL11A knockdown:control;SRX4317511,SRX4317512,SRX4317513,SRX4317514: knockdown;SRX4317515,SRX4317516,SRX4317517,SRX4317518;

SRP107327:control IL6Ra- versus IL6Ra+ in obese PBMC:IL6Ra-;SRX2833985,SRX2833986,SRX2833988:IL6Ra+;SRX2833984,SRX2833987,SRX2833989;

SRP107327:control IL6Ra- versus IL6Ra+ in lean PBMC:IL6Ra-;SRX2833991,SRX2833993,SRX2833995,SRX2833997:IL6Ra+;SRX2833990,SRX2833992,SRX2833994,SRX2833996;

**SRP107327: obese PBMC versus lean PBMC:obese;SRX2833984,SRX2833985,SRX2833986,SRX2833987,SRX2833988,SRX2833989:lean;SRX2833990,SRX2833991,SRX2833992,SRX2833993,SRX2833994,SRX2833995,SRX2833996,SRX2833997;

SRP111557:non-diabetic versus Type II diabetic:non-diabetic;SRX2996334,SRX2996335,SRX2996336,SRX2996337,SRX2996338,SRX3413848:Type II diabetic;SRX2996339,SRX2996340,SRX3413849;sex,age,BMI

SRP115040:normo-glycemic versus long duration type 1 diabetes:normo-glycemic;SRX3070956,SRX3070957,SRX3070958:long duration T1D;SRX3070959;

SRP115040:normo-glycemic versus long duration type 1 diabetes:normo-glycemic;SRX3070956,SRX3070957,SRX3070958:short duration T1D;SRX3070960;

**longT1D versus short T1D????

SRP144623:wild-type early stage pancreatic progenitors (PP1) versus wild-type late stage pancreatic progenitors (PP2):WP PP1;SRX4042188,SRX4042189:WT PP2;SRX4042190,SRX4042191,SRX4042192;

SRP144623:wild-type late stage pancreatic progenitors (PP2) versus GLIS3-/- PP2:WT PP2;SRX4042190,SRX4042191,SRX4042192:GLIS3-/- PP2;SRX4042193,SRX4042194,SRX4042195;

SRP144623:wild-type late stage pancreatic progenitors (PP2) versus WT INS-GFP+ PP2:WT PP2;SRX4042190,SRX4042191,SRX4042192:INS-GFP+ PP2;SRX4042198,SRX4042199;

SRP144623:wild-type early stage pancreatic progenitors (PP1) versus WT INS-GFP+ PP1:WP PP1;SRX4042188,SRX4042189:WT INS-GFP+ PP1;SRX4042196,SRX4042197;

SRP144623:GLIS3 PP2 versus GLIS3-/- INS-GFPT PP2:GLIS3 PP2;SRX4042193,SRX4042194,SRX4042195:GLIS3-/- INS-GFPT PP2;SRX4042200,SRX4042201;

SRP154717:pericytes cultured in control versus diabetic:control;SRX4415408,SRX4415409,SRX4415410,SRX4415417,SRX4415418,SRX4415419:diabetic;SRX4415423,SRX4415424,SRX4415425;sex

SRP154717:pericytes cultured in diabetic versus pDAPT:diabetic;SRX4415423,SRX4415424,SRX4415425:pDAPT;SRX4415429,SRX4415430,SRX4415431;sex

SRP154717:endothelial cell cultured in control versus diabetic:control;SRX4415405,SRX4415406,SRX4415407,SRX4415414,SRX4415415,SRX4415416:diabetic;SRX4415420,SRX4415421,SRX4415422;sex
,
SRP154717:endothelial cell cultured in diabetic versus pDAPT:diabetic;SRX4415420,SRX4415421,SRX4415422:pDAPT;SRX4415426,SRX4415427,SRX4415428;sex

SRP163900:UN (untreated) versus IL15 in ex vivo:UN;SRX4804447,SRX4804454,SRX4804461,SRX4804468,SRX4804475:IL15;SRX4804441,SRX4804448,SRX4804455,SRX4804462,SRX4804469;

SRP163900:IL15 versus IL15+BNZ in ex vivo:IL15;SRX4804441,SRX4804448,SRX4804455,SRX4804462,SRX4804469:IL15+BNZ;SRX4804442,SRX4804449,SRX4804456,SRX4804463,SRX4804470;

SRP163900:IL15 versus IL15+IL21 in ex vivo:IL15;SRX4804441,SRX4804448,SRX4804455,SRX4804462,SRX4804469:IL15+IL21;SRX4804443,SRX4804450,SRX4804457,SRX4804464,SRX4804471;

SRP163900:IL15+IL21 versus IL15+IL21+BNZ in ex vivo:IL15+IL21;SRX4804443,SRX4804450,SRX4804457,SRX4804464,SRX4804471:IL15+IL21+BNZ;SRX4804444,SRX4804451,SRX4804458,SRX4804465,SRX4804472;

SRP163900:UN versus IL21 in ex vivo:UN;SRX4804447,SRX4804454,SRX4804461,SRX4804468,SRX4804475:IL21;SRX4804445,SRX4804452,SRX4804459,SRX4804466,SRX4804473;

SRP163900:IL21 versus Il21+BNZ in ex vivo:IL21;SRX4804445,SRX4804452,SRX4804459,SRX4804466,SRX4804473:Il21+BNZ;SRX4804446,SRX4804453,SRX4804460,SRX4804467,SRX4804474;

SRP163900:UN versus IL15 in in vitro:UN;SRX4804485,SRX4804495,SRX4804505,SRX4804515,SRX4804519,SRX4804523,SRX4804527:IL15;SRX4804476,SRX4804486,SRX4804496,SRX4804506;

SRP163900:IL15 versus IL15+BNZ in in vitro:IL15;SRX4804476,SRX4804486,SRX4804496,SRX4804506:IL15+BNZ;SRX4804477,SRX4804487,SRX4804497,SRX4804507;

SRP163900:IL15 versus IL15+IL21 in in vitro:IL15;SRX4804476,SRX4804486,SRX4804496,SRX4804506:Il15+IL21;SRX4804479,SRX4804489,SRX4804499,SRX4804509;

SRP163900:IL15+IL21 versus IL15+IL21+BNZ in in vitro:IL15+IL21;SRX4804479,SRX4804489,SRX4804499,SRX4804509:IL15+IL21+BNZ;SRX4804480,SRX4804490,SRX4804500,SRX4804510;

SRP163900:UN versus IL21 in in vitro:UN;SRX4804485,SRX4804495,SRX4804505,SRX4804515,SRX4804519,SRX4804523,SRX4804527:IL21;SRX4804482,SRX4804492,SRX4804502,SRX4804512,SRX4804516,SRX4804520,SRX4804524;

SRP163900:IL21 versus Il21+BNZ in in vitro:IL21;SRX4804482,SRX4804492,SRX4804502,SRX4804512,SRX4804516,SRX4804520,SRX4804524:IL21+BNZ;SRX4804483,SRX4804493,SRX4804503,SRX4804513,SRX4804517,SRX4804521,SRX4804525;

SRP163900:IL21 versus IL21+CP in in vitro:IL21;SRX4804482,SRX4804492,SRX4804502,SRX4804512,SRX4804516,SRX4804520,SRX4804524:IL21+CP;SRX4804484,SRX4804494,SRX4804504,SRX4804514,SRX4804518,SRX4804522,SRX4804526;

SRP163900:IL15 versus Il15+CP in in vitro:IL15;SRX4804476,SRX4804486,SRX4804496,SRX4804506:IL15+CP;SRX4804478,SRX4804488,SRX4804498,SRX4804508;

SRP163900:IL15+IL21 versus IL15+IL21+CP in in vitro:IL15+IL21;SRX4804479,SRX4804489,SRX4804499,SRX4804509:IL15+IL21+CP;SRX4804481,SRX4804491,SRX4804501
,SRX4804511;

SRP029281:alpha versus beta cells:alpha;SRX340815,SRX340817,SRX340819:beta;SRX340816,SRX340818,SRX340820;

SRP029281:alpha versus exocrine cells:alpha;SRX340815,SRX340817,SRX340819:exocrine;SRX340821,SRX340822;

SRP029281:beta versus exocrine cells:beta;SRX340816,SRX340818,SRX340820:exocrine;SRX340821,SRX340822;

SRP121799:diabetic versus non-diabetic CMSC:diabetic;SRX3327085,SRX3327086,
SRX3327087,SRX3327088,SRX3327089,SRX3327090,SRX3327091:non-diabetic;SRX3327092,SRX3327093,SRX3327094,SRX3327095,SRX3327096,SRX3327097,SRX3327098;

SRP081605: Genes expressed differentially in whole blood samples in responders vs control in teplizumab treatment after 6 months:Ctrl;	SRX2018880,SRX2018882,SRX2018885,SRX2018887,SRX2018889,SRX2018892,SRX2018895,SRX2018896,SRX2018897,SRX2018905,	SRX2018908,SRX2018909,SRX2018911,SRX2018913,SRX2018914:Responders;	SRX2018890,SRX2018891,SRX2018893,SRX2018900,	SRX2018901,SRX2018902,SRX2018906,SRX2018910,SRX2018915,SRX2018916,SRX2018919,SRX2018920,SRX2018875,SRX2018876,	SRX2018884,SRX2018888

SRP081605: Genes expressed differentially in whole blood samples in responders vs non-responders in teplizumab treatment after 6 months:Non-responders; SRX2018922,SRX2018877,SRX2018878,SRX2018879,SRX2018881,SRX2018883,SRX2018886,SRX2018894,	SRX2018898,	SRX2018899,SRX2018903,SRX2018904,SRX2018907,SRX2018912,	SRX2018917,SRX2018921,SRX2018918:Responders; SRX2018890,SRX2018891,SRX2018893,SRX2018900,SRX2018901,SRX2018902,SRX2018906,SRX2018910,SRX2018915,SRX2018916,SRX2018919,SRX2018920,SRX2018875,SRX2018876,SRX2018884,SRX2018888

SRP081605: Genes expressed differentially in whole blood samples in responders vs control in teplizumab treatment after 12 months:Ctrl;	SRX2018789,SRX2018791,SRX2018793,SRX2018795,SRX2018797,SRX2018798,SRX2018801,SRX2018802,SRX2018805,SRX2018806,	SRX2018807,SRX2018810,SRX2018817,SRX2018818,SRX2018823,SRX2018826:Responders;	SRX2018814,SRX2018816,SRX2018819,SRX2018820,	SRX2018824,SRX2018825,SRX2018827,SRX2018813,SRX2018787,SRX2018799,SRX2018803,SRX2018808,SRX2018809

SRP081605: Genes expressed differentially in whole blood samples in responders vs non-responders in teplizumab treatment after 12 months:Non-responders; SRX2018788,SRX2018790,SRX2018792,SRX2018794,SRX2018796,SRX2018800,SRX2018804,SRX2018811,SRX2018812,SRX2018815,SRX2018821,SRX2018822,SRX2018828,SRX2018829:Responders;SRX2018814,SRX2018816,SRX2018819,SRX2018820,	SRX2018824,SRX2018825,SRX2018827,SRX2018813,SRX2018787,SRX2018799,SRX2018803,SRX2018808,SRX2018809

SRP081605: Genes expressed differentially in whole blood samples in responders vs control in teplizumab treatment after 24 months:Ctrl;	SRX2018923,SRX2018929,SRX2018932,SRX2018935,SRX2018937,SRX2018941,SRX2018943,SRX2018945,SRX2018953,	SRX2018956,	SRX2018959,SRX2018960,SRX2018961,SRX2018964,SRX2018965,SRX2018968,SRX2018973:Responders; SRX2018924,SRX2018931,SRX2018936,	SRX2018938,SRX2018939,SRX2018940,SRX2018942,SRX2018948,SRX2018949,SRX2018950,SRX2018954,SRX2018957,	SRX2018966,SRX2018967,SRX2018970,SRX2018971,SRX2018972

SRP081605: Genes expressed differentially in whole blood samples in responders vs non-responders in teplizumab treatment after 24 months:non-responders; SRX2018925,SRX2018926,SRX2018927,SRX2018928,SRX2018930,SRX2018933,SRX2018934,SRX2018944,SRX2018946,SRX2018947,SRX2018951,SRX2018952,SRX2018955,SRX2018958,SRX2018962,SRX2018963,SRX2018969,SRX2018974,SRX2018975,SRX2018976:Responders; SRX2018924,SRX2018931,SRX2018936,SRX2018938,SRX2018939,SRX2018940,SRX2018942,SRX2018948,SRX2018949,SRX2018950,SRX2018954,SRX2018957,SRX2018966,SRX2018967,SRX2018970,SRX2018971,SRX2018972

SRP090853: Genes expressed differentially regulated in cancer cells by the suppression of mNT:Ctrl; SRX2210964,SRX2210965,SRX2210966:mNTsupres;SRX2210967,SRX2210968,SRX2210969

SRP102710: Genes expressed differentially in brown adipose tissue vs omental fat:BAT;	SRX2683725,SRX2683726,SRX2683727,SRX2683728:OME;	SRX2683729,SRX2683730,SRX2683731

SRP102710: Genes expressed differentially in brown adipose tissue vs subcutaneous fat:BAT;SRX2683725,SRX2683726,SRX2683727,SRX2683728:SUB; 	SRX2683732,SRX2683733,SRX2683734

SRP102710: Genes expressed differentially in omental fat vs subcutaneous fat:OME;	SRX2683729,SRX2683730,SRX2683731:SUB; 	SRX2683732,SRX2683733,SRX2683734

SRP095538: Genes expressed differentially in glucose tolerant vs gestational diabetes sncRNA-Seq:Ctrl;SRX2440262,SRX2440264,SRX2440266,SRX2440268,SRX2440270,SRX2440272,SRX2440274,SRX2440276:GDM; SRX2440263,SRX2440265,SRX2440267,SRX2440269,SRX2440271,SRX2440273,SRX2440275,SRX2440277

SRP095538: Genes expressed differentially in glucose tolerant vs gestational diabetes RNA-Seq:Ctrl;	SRX2440278,SRX2440280,SRX2440282,SRX2440284,SRX2440286,SRX2440288,SRX2440290,SRX2440292:GDM;	SRX2440279,SRX2440281,SRX2440283,SRX2440285,SRX2440287,SRX2440289,SRX2440291,SRX2440293

SRP095512: Genes expressed differentially in health vs diabetic dermal endothelial cells:Ctrl; SRX2439830,SRX2439835,SRX2439836,SRX2439837,SRX2439838,SRX2439839:T2D; SRX2439831,SRX2439832,SRX2439833,SRX2439834

SRP102542: Genes expressed differentially in young people who do HIIT training:Ctrl;SRX2676303,SRX2676313,SRX2676315,SRX2676327, SRX2676329,SRX2676333,SRX2676346,SRX2676352,SRX2676360,SRX2676364,SRX2676396:HIIT;	SRX2676304,SRX2676314,SRX2676316,SRX2676328,SRX2676330,SRX2676334,SRX2676347,SRX2676353,SRX2676361,SRX2676365,SRX2676397

SRP102542: Genes expressed differentially in young people who do Resistance training:Ctrl;	SRX2676305,SRX2676309,SRX2676311,SRX2676317,SRX2676331,SRX2676338,SRX2676342,SRX2676348,SRX2676358,SRX2676362:Resis;SRX2676306,SRX2676312,SRX2676310,SRX2676318,SRX2676332,SRX2676339,SRX2676343,SRX2676349,SRX2676359,SRX2676363

SRP102542: Genes expressed differentially in young people who do Resistance and HIIT training:Ctrl;	SRX2676301,SRX2676307,SRX2676323,SRX2676335,SRX2676340,SRX2676344,SRX2676354,SRX2676366:R&H;	SRX2676302,SRX2676308,SRX2676324,SRX2676341,SRX2676345,SRX2676355,SRX2676367

SRP102542: Genes expressed differentially in old people who do HIIT training:Ctrl; SRX2676325,SRX2676368,SRX2676374,SRX2676378,SRX2676384,SRX2676388,SRX2676390,SRX2676392:HIIT;	SRX2676389,SRX2676391,SRX2676393,SRX2676326,SRX2676369,SRX2676375,SRX2676385,SRX2676379

SRP102542: Genes expressed differentially in old people who do resistance training:Ctrl; SRX2676336,SRX2676350,SRX2676370,SRX2676372,SRX2676382,SRX2676386,SRX2676400,SRX2676402:Resis; SRX2676337,SRX2676351,SRX2676371,SRX2676373,SRX2676383,SRX2676387,SRX2676401,SRX2676403

SRP102542: Genes expressed differentially in old people who do Resistance and HIIT training:Ctrl;	SRX2676319,SRX2676321,SRX2676356,SRX2676376,SRX2676380,SRX2676394,SRX2676398:H&R; SRX2676320,SRX2676322,SRX2676341,SRX2676377,SRX2676381,SRX2676395,SRX2676399

SRP097696: retinal endothelial cells from non-diabetic controls versus fibrovascular membrane endothelial cells from proliferative diabetic retinopathy: non-diabetic control; SRX2513447, SRX2513448, SRX2513458, SRX2513459: proliferative diabetic retinopathy; SRX2513449, SRX2513450, SRX2513451, SRX2513452, SRX2513453, SRX2513454, SRX2513455, SRX2513456, SRX2513457;

SRP101810: bulk-cell RNA-seq of unstimulated T cell clone versus anti-CD3 anti-CD28 monoclonal antibodies stimulated T cell clone: unstimulated T cell clone; SRX2637128, SRX2637129, SRX2637130: anti-CD3 anti-CD28 stimulated T cell clone; SRX2637126, SRX2637131, SRX2637133;

SRP101810: bulk-cell RNA-seq of unstimulated T cell clone versus GAD peptide-loaded tetramer stimulated T cell clone: unstimulated T cell clone; SRX2637128, SRX2637129, SRX2637130: tetramer stimulated T cell clone; SRX2637127, SRX2637132, SRX2637134;

SRP101810: bulk-cell RNA-seq of anti-CD3 anti-CD28 monoclonal antibodies stimulated T cell clone versus GAD peptide-loaded tetramer stimulated T cell clone: anti-CD3 anti-CD28 stimulated T cell clone; SRX2637126, SRX2637131, SRX2637133: tetramer stimulated T cell clone; SRX2637127, SRX2637132, SRX2637134;
